Rong Tao
Clinical trials sponsored by Rong Tao, explained in plain language.
-
New drug combo targets Tough-to-Treat lymphoma
Disease control Not yet recruitingThis study tests a combination of two drugs, tislelizumab and zeprumetostat, in people with a rare type of lymphoma (NK/T-cell) that has returned or not responded to prior treatment. About 107 adults will take part to find the best dose and measure how well the drugs shrink tumor…
Phase: PHASE1, PHASE2 • Sponsor: Rong Tao • Aim: Disease control
Last updated May 26, 2026 06:30 UTC
-
New drug aims to wipe out lingering lymphoma cells after remission
Disease control Not yet recruitingThis study tests a drug called chidamide in people with a type of lymphoma (double-expressor DLBCL) who are in remission after initial treatment but still have tiny amounts of cancer DNA in their blood. The goal is to see if taking chidamide pills can clear this hidden disease an…
Phase: PHASE2 • Sponsor: Rong Tao • Aim: Disease control
Last updated May 20, 2026 11:53 UTC